Failed IVF: When Should You Change Clinics or Seek a Second Opinion?

Even technically appropriate IVF can end without a pregnancy. That does not excuse missing consent, unclear costs or a failure to explain complications, but a negative result alone cannot prove substandard care. Look at whether clinical decisions were individualised, reports were shared, medication changes were documented and the team made itself accessible for time-sensitive questions. A provider who can explain uncertainty deserves a different assessment from one who promises success.

Ask for the stimulation protocol, medicine schedule, follicle monitoring, hormone results where taken, trigger and retrieval record, number and maturity of eggs, fertilisation method, embryology updates, freezing or biopsy details, and transfer notes. If there was no transfer, learn precisely where the pathway stopped. If there was a transfer, discuss the embryo information and any identified uterine factors. An opinion built only on a single beta hCG value lacks crucial context.

Embryo appearance is useful laboratory information, but it cannot reveal every genetic or biological factor. Likewise, good-looking embryos do not guarantee implantation. Ask which findings are genuinely unexpected for the patient’s age and diagnosis, and which reflect the limits of treatment. Clinicians should avoid over-interpreting a small number of embryos or presenting an unproven add-on as the missing answer.

A second opinion may be particularly helpful after unexpected fertilisation failure, repeatedly poor ovarian response, unresolved male-factor questions, difficult procedures, unexplained changes in treatment or a concern about the quality of informed consent. It can also help when partners feel unable to ask questions. A qualified specialist may suggest staying with the original team and modifying the plan; that is still a useful outcome.

Embryos in storage, consent forms, laboratory policies and the costs of transporting cryopreserved material require special attention. A prospective new clinic should explain what records it needs, whether it accepts external embryos, and how chain-of-custody and storage continuity would work if transfer is necessary. Do not assume that an already frozen embryo must be moved. If the existing clinic can conduct a planned transfer safely, that option deserves fair consideration.

A clinic change may come with proposals for repeated hysteroscopy, immune tests, endometrial receptivity assays or other interventions. Each should be discussed on the basis of the patient’s findings and actual evidence. Ask whether the test changes a clinical action or only creates another result to worry about. Money saved from an unnecessary add-on may be better reserved for treatment or financial and emotional recovery.

When reviewing two clinics, compare their answers to identical questions rather than their advertising claims. What did the previous cycle show about ovarian response? Was fertilisation unexpectedly low, or was embryo development consistent with the number of mature eggs? Was embryo transfer technically straightforward? Is there a diagnosis that was not previously investigated? A clinician who says that more information is needed may be acting more responsibly than someone who immediately promises a new proprietary protocol will solve the problem.

Also ask how you would be supported between visits. If results arrive late in the day, who can explain them? If a medication is changed, is the new instruction documented? If a complication arises at home, where should you go? Changing a clinic can be worthwhile for communication and continuity even when the underlying treatment approach remains similar. Conversely, a centre with an impressive website is not automatically a better choice. The decision should integrate medical reasoning, patient experience, financial transparency and practical access.

HomeIVF may help organise a doctor-led records review or fertility second-opinion discussion remotely, reducing travel simply to explain documents. Availability of teleconsultation, home blood collection or injection support must be confirmed in the patient’s location. A second opinion cannot examine embryos at home or replace facility-based ultrasound, egg retrieval, laboratory work, transfer or emergency assessment. Any suggested switch should preserve medical continuity.

Create a factual cycle timeline with dates and outcomes, then ask two clinicians the same questions: where did the cycle stop, what change is supported by evidence, and what would be done if the next cycle behaves similarly? Compare the quality of their reasoning before comparing branding, fee discounts or anecdotes.